These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 5971773)

  • 1. Substrate and dilution effects on the inhibition of acetylcholinesterase by carbamates.
    Winteringham FP; Fowler KS
    Biochem J; 1966 Oct; 101(1):127-34. PubMed ID: 5971773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the kinetics of inhibition of rat-brain acetylcholine esterase by Sevin.
    Hassan A; Abdel-Hamid FM; Bahig MR
    Z Naturforsch B; 1967 May; 22(5):505-7. PubMed ID: 4384852
    [No Abstract]   [Full Text] [Related]  

  • 3. The kinetics of inhibition of erythrocyte cholinesterase by monomethylcarbamates.
    Reiner E; Simeon-Rudolf V
    Biochem J; 1966 Feb; 98(2):501-5. PubMed ID: 5941343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microcalorimetric study of the inhibition of butyrylcholinesterase by carbamates.
    Debord J; Laubarie C; Dantoine T
    Anal Biochem; 2008 Feb; 373(2):247-52. PubMed ID: 17950687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of charge on the carbamylation and binding constants of eel acetylcholinesterase in reaction with neostigmine and related carbamates.
    Iverson F; Main AR
    Biochemistry; 1969 May; 8(5):1889-95. PubMed ID: 5785211
    [No Abstract]   [Full Text] [Related]  

  • 6. Carbamate analogues of (-)-physostigmine: in vitro inhibition of acetyl- and butyrylcholinesterase.
    Yu QS; Atack JR; Rapoport SI; Brossi A
    FEBS Lett; 1988 Jul; 234(1):127-30. PubMed ID: 3391264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbamylation and binding constants for the inhibition of acetylcholinesterase by physostigmine (eserine).
    Main AR; Hastings FL
    Science; 1966 Oct; 154(3747):400-2. PubMed ID: 5917090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxime effects on the rate constants of carbamylation and decarbamylation of acetylcholinesterase for pyridostigmine, physostigmine and insecticidal carbamates.
    Dawson RM
    Neurochem Int; 1995 Jun; 26(6):643-54. PubMed ID: 7670367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physostigmine analogs anticholinesterases: effects of the lengthening of the N-carbamic chain on the inhibition kinetics.
    Marta M; Gatta F; Pomponi M
    Biochim Biophys Acta; 1992 Apr; 1120(3):262-6. PubMed ID: 1576152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic characterization of all steps of the interaction between acetylcholinesterase and eserine.
    Stojan J; Zorko M
    Biochim Biophys Acta; 1997 Jan; 1337(1):75-84. PubMed ID: 9003439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new method to characterize the kinetics of cholinesterases inhibited by carbamates.
    Xiao Q; Zhou H; Wei H; Du H; Tan W; Zhan Y; Pistolozzi M
    J Pharm Biomed Anal; 2017 Sep; 144():175-182. PubMed ID: 28483282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate constants of carbamylation and decarbamylation of acetylcholinesterase for physostigmine and carbaryl in the presence of an oxime.
    Dawson RM
    Neurochem Int; 1994 Feb; 24(2):173-82. PubMed ID: 8161944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition and protection of cholinesterases by methanol and ethanol.
    Fekonja O; Zorec-Karlovsek M; El Kharbili M; Fournier D; Stojan J
    J Enzyme Inhib Med Chem; 2007 Aug; 22(4):407-15. PubMed ID: 17847706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition and reactivation of acetylcholinesterase.
    Wilson EB
    Ann N Y Acad Sci; 1966 Jan; 135(1):177-83. PubMed ID: 5221339
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure-activity relationships for insecticidal carbamates.
    Metcalf RL
    Bull World Health Organ; 1971; 44(1-3):43-78. PubMed ID: 5315358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nature of the reaction of organophosphorus compounds and carbamates with esterases.
    Aldridge WN
    Bull World Health Organ; 1971; 44(1-3):25-30. PubMed ID: 5315347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure-activity relationships for the pre-steady state acetylcholinesterase inhibition by carbamates.
    Lin G; Liao WC; Chan CH; Wu YH; Tsai HJ; Hsieh CW
    J Biochem Mol Toxicol; 2004; 18(6):353-60. PubMed ID: 15674842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identical kinetics of human erythrocyte and muscle acetylcholinesterase with respect to carbamate pre-treatment, residual activity upon soman challenge and spontaneous reactivation after withdrawal of the inhibitors.
    Herkert NM; Eckert S; Eyer P; Bumm R; Weber G; Thiermann H; Worek F
    Toxicology; 2008 Apr; 246(2-3):188-92. PubMed ID: 18304715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human fetal brain acetylcholinesterase: marker effect of neurotoxicity.
    Banerjee J; Ghosh P; Mitra S; Ghosh N; Bhattacharya S
    J Toxicol Environ Health; 1991 Jul; 33(3):283-90. PubMed ID: 1906943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of carbamate drugs. I. Metabolism of 1-naphthyl-N-methyl carbamate (Sevin) in the rat.
    Hassan A; Zayed SM; Abdel-Hamid FM
    Biochem Pharmacol; 1966 Dec; 15(12):2045-55. PubMed ID: 5973174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.